Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Drapkin

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Cancer Discovery|January 13, 2025
Atypical Small Cell Lung Cancer: A New Malignancy Characterized by Chromothripsis, Carcinoid Tumors, and Wild-type RB1 and TP53Urooba Nadeem, Benjamin J Drapkin
Trends in Pharmacological Sciences|April 13, 2019
Unexpected Synergy Reveals New Therapeutic Strategy in SCLCBenjamin J Drapkin, Anna F Farago
Cold Spring Harbor Perspectives in Medicine|June 10, 2020
Advances in Small-Cell Lung Cancer (SCLC) Translational ResearchBenjamin J Drapkin, Charles M Rudin
Cancer Cell|August 12, 2020
Studying Lineage Plasticity One Cell at a TimeBenjamin J Drapkin, John D Minna
Cancer Cell|April 13, 2021
A rational targeted therapy for platinum-resistant small-cell lung cancerBenjamin J Drapkin, John D Minna
Cell|January 5, 2024
Proteomics: A new dimension to decode small cell lung cancerHaobin Chen, Benjamin J Drapkin, John D Minna
Elife|August 4, 2021
How lung cancer cells change identityMitchell S von Itzstein, Benjamin J Drapkin, John D Minna
Molecular and Cellular Biology|July 19, 2005
Disruption of mechanisms that prevent rereplication triggers a DNA damage responseVincent Archambault, Amy E Ikui, Benjamin J Drapkin, et al.
Genetics|December 30, 2006
Cyclin and cyclin-dependent kinase substrate requirements for preventing rereplication reveal the need for concomitant activation and inhibitionAmy E Ikui, Vincent Archambault, Benjamin J Drapkin, et al.
Frontiers in Oncology|November 3, 2025
Marked under-diagnosis of Lambert-Eaton myasthenic syndrome in small cell lung cancer: an analysis of real-world claims dataBenjamin J Drapkin, David J Morrell, Regina Grebla, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cancer Discovery|January 13, 2025
Atypical Small Cell Lung Cancer: A New Malignancy Characterized by Chromothripsis, Carcinoid Tumors, and Wild-type RB1 and TP53Urooba Nadeem, Benjamin J Drapkin
Trends in Pharmacological Sciences|April 13, 2019
Unexpected Synergy Reveals New Therapeutic Strategy in SCLCBenjamin J Drapkin, Anna F Farago
Cold Spring Harbor Perspectives in Medicine|June 10, 2020
Advances in Small-Cell Lung Cancer (SCLC) Translational ResearchBenjamin J Drapkin, Charles M Rudin
Cancer Cell|August 12, 2020
Studying Lineage Plasticity One Cell at a TimeBenjamin J Drapkin, John D Minna
Cancer Cell|April 13, 2021
A rational targeted therapy for platinum-resistant small-cell lung cancerBenjamin J Drapkin, John D Minna
Cell|January 5, 2024
Proteomics: A new dimension to decode small cell lung cancerHaobin Chen, Benjamin J Drapkin, John D Minna
Elife|August 4, 2021
How lung cancer cells change identityMitchell S von Itzstein, Benjamin J Drapkin, John D Minna
Molecular and Cellular Biology|July 19, 2005
Disruption of mechanisms that prevent rereplication triggers a DNA damage responseVincent Archambault, Amy E Ikui, Benjamin J Drapkin, et al.
Genetics|December 30, 2006
Cyclin and cyclin-dependent kinase substrate requirements for preventing rereplication reveal the need for concomitant activation and inhibitionAmy E Ikui, Vincent Archambault, Benjamin J Drapkin, et al.
Frontiers in Oncology|November 3, 2025
Marked under-diagnosis of Lambert-Eaton myasthenic syndrome in small cell lung cancer: an analysis of real-world claims dataBenjamin J Drapkin, David J Morrell, Regina Grebla, et al.
Pageof 4